DBV TECHNOLOGIES (EPA:DBV) | WebDisclosure

Basculer en Français

10356	Companies
215523	Keywords
145330	Articles
114170	Press releases

Home
Companies
DBV TECHNOLOGIES

PRESS RELEASE

published on 11/12/2025 at 05:50, 5 months 25 days ago

DBV Technologies annonce la dernière visite du dernier patient dans l'essai clinique de phase 3 VITESSE du patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans allergiques aux arachides
DBV Technologies annonce la fin de la dernière visite du dernier patient dans l'essai clinique de phase 3 VITESSE du patch VIASKIN® Peanut chez les enfants allergiques aux arachides, se rapprochant ainsi de la publication des résultats préliminaires

Essai Clinique DBV Technologies Patch Viaskin Peanut Enfants Allergiques Phase 3 VITESSE
BRIEF

published on 11/04/2025 at 22:35, 6 months 2 days ago

DBV Technologies is participating in a healthcare innovation conference

DBV Technologies Viaskin Food Allergies Health Conference EPIT
BRIEF

published on 11/04/2025 at 22:35, 6 months 2 days ago

DBV Technologies participe à une conférence sur l'innovation en santé

DBV Technologies Allergies Alimentaires Viaskin Conférence Santé EPIT
PRESS RELEASE

published on 11/04/2025 at 22:30, 6 months 2 days ago

DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
DBV Technologies to participate in Guggenheim 2nd Annual Healthcare Innovation Conference with CEO Daniel Tassé at the helm, discussing treatment options for food allergies

Healthcare Innovation DBV Technologies Food Allergies VIASKIN Patch Guggenheim Conference
PRESS RELEASE

published on 11/04/2025 at 22:30, 6 months 2 days ago

DBV Technologies participera à la 2e conférence annuelle Guggenheim Healthcare Innovation
DBV Technologies participera à la 2e conférence annuelle Guggenheim Healthcare Innovation avec Daniel Tassé, Directeur Général. Découvrez la webdiffusion en direct sur le patch VIASKIN® pour les allergies alimentaires

Conférence Annuelle DBV Technologies Allergies Alimentaires Patch VIASKIN® Guggenheim Healthcare Innovation
BRIEF

published on 10/30/2025 at 21:35, 6 months 7 days ago

DBV Technologies Appoints Philina Lee, Ph.D. to Board of Directors

Board Of Directors Biopharmaceutical DBV Technologies Viaskin Peanut Philina Lee
BRIEF

published on 10/30/2025 at 21:35, 6 months 7 days ago

DBV Technologies nomme Philina Lee, Ph.D., à son conseil d'administration

Conseil D'administration Biopharmaceutique VIASKIN Cacahuète Philina Lee Technologies DBV
PRESS RELEASE

published on 10/30/2025 at 21:30, 6 months 7 days ago

DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
DBV Technologies appoints Dr. Philina Lee, Ph.D. as independent director to Board of Directors, bringing extensive biopharmaceutical experience. Company focused on VIASKIN® Peanut for food allergies

Board Of Directors DBV Technologies Food Allergies Viaskin Peanut Dr. Philina Lee
PRESS RELEASE

published on 10/30/2025 at 21:30, 6 months 7 days ago

DBV Technologies annonce la nomination de Philina Lee, Ph.D. au sein de son Conseil d’administration
DBV Technologies nomme Philina Lee, Ph.D. au Conseil d’administration et Comité des rémunérations. Lee apporte son expertise en biopharmaceutique et commercialisation. DBV se concentre sur le traitement des allergies alimentaires

Conseil D'administration Biopharmaceutique DBV Technologies Allergies Alimentaires Philina Lee
BRIEF

published on 10/28/2025 at 21:30, 6 months 9 days ago

DBV Technologies annonce ses résultats financiers du T3 2025

Résultats Financiers Financement Trésorerie Perte Nette Viaskin Peanut

Accesswire

Published on 05/07/2026 at 05:40, 37 minutes ago

New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 4 hours 17 minutes ago

Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 6 hours 47 minutes ago

Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 7 hours 12 minutes ago

Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 7 hours 17 minutes ago

Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 04:00, 2 hours 17 minutes ago

L’Université chinoise de Hong Kong (CUHK) se classe en tête à Hong Kong et en Asie dans le dernier classement mondial des universités par discipline publié par QS (Quacquarelli Symonds)
Published on 05/07/2026 at 04:00, 2 hours 17 minutes ago

CUHK Claims Top Positions in Hong Kong and Asia in the Latest QS World University Rankings by Subject
Published on 05/07/2026 at 03:50, 2 hours 27 minutes ago

450 MHz LTE: Stronger, Smarter Grid for Brazil
Published on 05/07/2026 at 00:47, 5 hours 30 minutes ago

Blue Cap AG expands portfolio through the acquisition of Janoschka AG
Published on 05/07/2026 at 00:43, 5 hours 33 minutes ago

EQS-Adhoc: Blue Cap AG Acquires Janoschka AG and Adjusts Forecast Due to Transaction

Les Echos

Published on 05/06/2026 at 18:00, 12 hours 17 minutes ago

Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 12 hours 17 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 12 hours 17 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 12 hours 17 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 12 hours 32 minutes ago

Information concerning the total number of voting rights and shares 2026 04 30

View all LES ECHOS COMFI WIRE